242 related articles for article (PubMed ID: 26472259)
21. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
22. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
Yee KK; Soo KC; Olivo M
Int J Mol Med; 2005 Dec; 16(6):993-1002. PubMed ID: 16273277
[TBL] [Abstract][Full Text] [Related]
23. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
24. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
[TBL] [Abstract][Full Text] [Related]
25. Co-delivery of Doxorubicin Encapsulated PLGA Nanoparticles and Bcl-xL shRNA Using Alkyl-Modified PEI into Breast Cancer Cells.
Ebrahimian M; Taghavi S; Mokhtarzadeh A; Ramezani M; Hashemi M
Appl Biochem Biotechnol; 2017 Sep; 183(1):126-136. PubMed ID: 28236188
[TBL] [Abstract][Full Text] [Related]
26. Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth.
Budi HS; Izadi S; Timoshin A; Asl SH; Beyzai B; Ghaderpour A; Alian F; Eshaghi FS; Mousavi SM; Rafiee B; Nikkhoo A; Ahmadi A; Hassannia H; Ahmadi M; Sojoodi M; Jadidi-Niaragh F
Nanomedicine; 2021 Jun; 34():102373. PubMed ID: 33667724
[TBL] [Abstract][Full Text] [Related]
27. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model.
Ben David-Naim M; Grad E; Aizik G; Nordling-David MM; Moshel O; Granot Z; Golomb G
Biomaterials; 2017 Nov; 145():154-167. PubMed ID: 28863309
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells.
Karpisheh V; Fakkari Afjadi J; Nabi Afjadi M; Haeri MS; Abdpoor Sough TS; Heydarzadeh Asl S; Edalati M; Atyabi F; Masjedi A; Hajizadeh F; Izadi S; Mirzazadeh Tekie FS; Hajiramezanali M; Sojoodi M; Jadidi-Niaragh F
Int J Biol Macromol; 2021 Jan; 167():1006-1019. PubMed ID: 33227333
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y
Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460
[No Abstract] [Full Text] [Related]
30. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
[TBL] [Abstract][Full Text] [Related]
31. Polyethylenimine as a promising vector for targeted siRNA delivery.
Nimesh S
Curr Clin Pharmacol; 2012 May; 7(2):121-30. PubMed ID: 22432843
[TBL] [Abstract][Full Text] [Related]
32. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
33. A light-triggerable formulation to control the stability of pro-angiogenic transcription factor hypoxia inducible factor-1α (HIF-1α).
Blersch J; Francisco V; Rebelo C; Jiménez-Balsa A; Antunes H; Pinto S; Simões S; Rai A; Ferreira L
Nanoscale; 2020 May; 12(18):9935-9942. PubMed ID: 32352454
[TBL] [Abstract][Full Text] [Related]
34. A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids.
Wen J; Qiu N; Zhu Z; Bai P; Hu M; Qi W; Liu Y; Wei A; Chen L
Drug Deliv; 2021 Dec; 28(1):1055-1066. PubMed ID: 34078185
[TBL] [Abstract][Full Text] [Related]
35. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
[TBL] [Abstract][Full Text] [Related]
36. Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model.
Kamlah F; Eul BG; Li S; Lang N; Marsh LM; Seeger W; Grimminger F; Rose F; Hänze J
Cancer Gene Ther; 2009 Mar; 16(3):195-205. PubMed ID: 18818708
[TBL] [Abstract][Full Text] [Related]
37. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
[TBL] [Abstract][Full Text] [Related]
38. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
Heo MB; Cho MY; Lim YT
Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
[TBL] [Abstract][Full Text] [Related]
39. Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound.
Bai M; Shen M; Teng Y; Sun Y; Li F; Zhang X; Xu Y; Duan Y; Du L
Oncotarget; 2015 Dec; 6(41):43779-90. PubMed ID: 26575421
[TBL] [Abstract][Full Text] [Related]
40. Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia.
Song M; Liu T; Shi C; Zhang X; Chen X
ACS Nano; 2016 Jan; 10(1):633-647. PubMed ID: 26650065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
